Skip to main content
NEXTURNBIOSCIENCE Co., LTD logo

NEXTURNBIOSCIENCE Co., LTD — Investor Relations & Filings

Ticker · 089140 ISIN · KR7089140008 KO Professional, scientific and technical activities
Open in API
Filings indexed 486 across all filing types
Latest filing 2023-06-21 Major Shareholding Noti…
Country KR South Korea
Listing KO 089140

About NEXTURNBIOSCIENCE Co., LTD

http://www.nexturn.co.kr

NEXTURNBIOSCIENCE Co., LTD. is a specialized manufacturer of Computer Numerical Control (CNC) automatic lathes, with a focus on Swiss-type models. The company develops and produces a range of machines, including both guide bush and non-guide bush types, utilizing proprietary technology. In addition to its core machinery business, NEXTURNBIOSCIENCE leverages its expertise in ultra-precision manufacturing to produce essential functional components. These high-quality parts serve critical applications across diverse sectors, including information technology (IT), construction equipment, and the medical industry, reflecting the company's expanding business scope.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document specifically details changes in share ownership (crossing reporting thresholds) and is commonly referred to as a 'Major Shareholding Notification' in international financial reporting contexts. It is not an announcement of a report, but the report itself.
2023-06-21 Korean
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the cancellation of a stock collateral agreement by a major shareholder. It details the repayment of debt and the subsequent release of pledged shares. This type of disclosure regarding financing arrangements and collateral status falls under general regulatory filings as it does not fit into specific categories like M&A, share issuance, or director dealings.
2023-06-20 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KIND) regarding the cancellation/release of a stock collateral agreement involving a major shareholder. It is a formal disclosure of a change in financial status related to share collateralization. Since it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Major Shareholding Notification' (which is for ownership threshold changes), and it is a specific regulatory disclosure regarding corporate financing/collateral, it falls under the 'Regulatory Filings' (RNS) category as the most appropriate fallback for miscellaneous corporate disclosures.
2023-06-20 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and a subsequent correction (정정신고) filed with the Korea Exchange. This type of regulatory filing, which details capital structure changes, financing, and specific terms of debt instruments, falls under the 'Capital/Financing Update' category.
2023-06-14 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) by Nexturn Bioscience. It details the terms of the bond issuance, including interest rates, conversion prices, put/call options, and the list of investors. This type of filing is a standard regulatory disclosure for capital raising activities in the Korean market, which falls under the 'Capital/Financing Update' category.
2023-06-13 Korean
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) by Nexturn Bioscience. It is titled 'Correction Report' (정정신고) regarding the 'Acquisition of Shares and Securities of Other Corporations' (타법인 주식 및 출자증권 양수결정). This is a standard corporate disclosure document detailing M&A-related activity, specifically the acquisition of shares in another entity. Since it details a specific transaction involving the acquisition of assets/shares, it falls under the M&A Activity category.
2023-05-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.